add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
Juvederm by Allergan | Injectable Filler Treatments Performed by Boston... bostonplastic.com | Allergan at Skin Care by MD skincarebymd.com | Allergan wins patent infringement suit over generic versions of brimonidin osnsupersite.com |
 Allergan, Inc., is a global specialty pharmaceutical company. Their product ranges include ophthalmic pharmaceuticals, dermatology products, and neurological products.
[edit] ProfileThe company's most notable neurologic product is Botox, used around the world to treat a variety of debilitating disorders associated with muscle overactivity and also well-known—under the tradenames Botox Cosmetic and Vistabel -- for the treatment of facial lines. Its most important manufacturing plants are in Waco, Texas, Westport, Ireland and San Jose, Costa Rica. [edit] History1950 Allergan launched its first product, NASAL DROPS 1962 Allergan achieves $1 Million in eye care sales 1966 Worldwide Corporate Headquarters was established in Irvine by acquiring a 28-acre (110,000 m2) parcel of land 1970 Allergan becomes Publicly traded and achieves $10 Million in sales 1978 Started Mfg in Ireland 1980 Subsidiaries are in 30 countries and products are marketed in more than 100 countries sales reach $100 Million 1980, the Company was acquired by SmithKline Beecham plc (then known as "SmithKline Corporation" and herein "SmithKline"). The Company operated as a wholly-owned subsidiary of SmithKline from 1980 until 1989 when Allergan again became a stand-alone public company through a spin-off distribution by SmithKline. 1992, the Company sold its contact lens business in North and South America. 1993, the Company sold its contact lens business outside of the Americas. 1994, the Company acquired the Ioptex Research worldwide intraocular lens product line. 1987 Allergan achieves $500 Million in sales 1995 Allergan achieves $1 Billion in sales 1995, the Company completed four acquisitions. In January 1995, the Company acquired Optical Micro Systems, Inc., a U.S.-based developer and manufacturer of phacoemulsification surgical equipment. In June 1995, the Company acquired Laboratorios Frumtost, S.A., a manufacturer of ophthalmic and other pharmaceutical products in Brazil. In August 1995, the Company purchased the assets of Herald Pharmacal, Inc., a U.S.-based developer and manufacturer of glycolic acid-based, aesthetic skin care products. In November 1995, the Company purchased the worldwide contact lens care product business of Pilkington Barnes Hind. Also in 1995, Allergan acquired 100% ownership interest in Santen-Allergan, its Japanese contact lens care joint venture. 1999 Allergan implemented a two-for-one stock split effected as a dividend to stockholders of record on November 18, 1999. 2002 Botox is born 2004 Allergan achieves $2 Billion in sales 2006 Allergan Achieves $3 Billion in sales 2006 Lap Band is born 2007 Breast implants developed(see "Inamed acquisition" below) In March 2006, Allergan acquired aesthetic company, Inamed, to create a world leading aesthetic brand focused on facial aesthetics, breast aesthetics, and devices designed to treat obesity(lapband). In February 2007, Allergan acquired the Swiss company Endoart SA based on the EPFL campus. It has special expertise in the field of telemetrically-controlled implants. Allergan is reported to be investigating the cosmetic properties of Lumigan in clinical trials as of November 2007.[1] 2009 Update: Allergan released above mentioned product under the name "Latisse", an attenuated version of Lumigan (same active ingredient, bimatoprost, in lower concentration). [edit] Products
[edit] External links
[edit] References[edit] Citations
| |||||||||||||||||||||
| ↑ top of page ↑ | about thumbshots |
